Biotech News
Delcath Systems Reports First Quarter 2026 Results and Business Highlights
delcathsystemsinc.gcs-web.com2026-05-07 12:06 EST
2026 Revenue Guidance of at least $100M Conference Call Today at 8:30 a.m. Eastern Time QUEENSBURY, N.Y. --(BUSINESS WIRE)--May 7, 2026-- Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of primary and metastatic liver cancers, today announced